14
Participants
Start Date
September 21, 2017
Primary Completion Date
June 30, 2019
Study Completion Date
June 30, 2019
Naltrexone for extended-release injectable suspension
Opioid-dependent Drug Court clients enrolled in the study will receive monthly injections of Vivitrol for up to 12 months if they continue to be medically eligible and willing.
Oral naltrexone
Opioid-dependent Drug Court clients enrolled in the study will receive prescriptions for oral naltrexone for up to 12 months if they continue to be medically eligible and willing.
Fellowship Health Resources (FHR), Raleigh
Lead Sponsor
Collaborators (1)
Laura and John Arnold Foundation
OTHER
Alkermes, Inc.
INDUSTRY
FHR (Fellowship Health Resources, Inc.)
OTHER
Wake County Recovery Court
FED
Duke University
OTHER